Calcium Replenishment in Hypocalcemia
For chronic hypocalcemia, start with oral calcium carbonate 500-1000 mg elemental calcium two to three times daily with meals, combined with vitamin D supplementation, while reserving intravenous calcium gluconate or calcium chloride for acute symptomatic cases or severe hypocalcemia (ionized calcium <0.8 mmol/L or total calcium <7.5 mg/dL).
Oral Calcium Supplementation
Choice of Calcium Salt
Calcium carbonate is the preferred first-line oral supplement due to its high elemental calcium content (40%), low cost, and widespread availability 1. Key considerations:
- Dosing: 500-1000 mg elemental calcium two to three times daily with meals
- Must be taken with food since gastric acidity improves absorption
- Common side effects include constipation and bloating 1
Calcium citrate is the alternative when:
- Patients are on chronic proton pump inhibitors or H2 blockers
- Gastric acidity is compromised
- Constipation is problematic with carbonate
- Contains 21% elemental calcium, requires larger tablets but doesn't need acid for absorption 1
Total Daily Requirements
Target elemental calcium intake based on age and sex 1:
- Adults 19-50 years: 1000 mg/day
- Women >50 years: 1200 mg/day
- Men 51-70 years: 1000 mg/day
- Men >70 years: 1200 mg/day
- Upper limit: Do not exceed 2000 mg/day in adults >50 years (2500 mg/day in younger adults)
Vitamin D Supplementation
Vitamin D is essential for calcium absorption and must be co-administered 2, 3. The approach depends on renal function:
- Normal renal function (eGFR ≥30 mL/min): Use cholecalciferol (vitamin D3) or ergocalciferol (vitamin D2) 4
- Severe renal impairment (eGFR <30 mL/min): May require active vitamin D (calcitriol, paricalcitol, or doxercalciferol) to maintain calcium balance 4
Critical pitfall: Vitamin D deficiency is a major contributor to hypocalcemia and must be corrected 5. In one study, vitamin D deficiency independently increased hypocalcemia risk 6.2-fold 5.
Magnesium Repletion
Check and correct magnesium deficiency before or concurrent with calcium replacement 3. Hypomagnesemia impairs PTH secretion and action, making hypocalcemia refractory to treatment until magnesium is normalized.
Intravenous Calcium Therapy
Indications for IV Calcium
Use intravenous calcium for 3, 6, 7:
- Severe symptomatic hypocalcemia (tetany, seizures, laryngospasm, cardiac arrhythmias)
- Ionized calcium <0.8 mmol/L (or total calcium <7.5 mg/dL with symptoms)
- Acute hypocalcemic crisis
- Patients unable to take oral medications
IV Administration Protocol
Acute management goal: Ameliorate symptoms, not necessarily normalize calcium 8
- Initial bolus: 1-2 ampules (10-20 mL) of 10% calcium gluconate IV over 10-20 minutes
- Continuous infusion: 10 ampules (100 mL) of 10% calcium gluconate in 1 liter D5W or normal saline at 50-100 mL/hour
- Monitor: Cardiac rhythm during administration; check ionized calcium every 4-6 hours initially 6, 7
Critical warning: IV calcium administration typically increases blood pressure but does not consistently increase cardiac output 7. When given with beta-adrenergic agonists, calcium may impair their cardiovascular effects 7.
Monitoring Strategy
Initial Phase
- Serum calcium (ionized preferred): Every 4-6 hours during acute treatment, then daily until stable
- Magnesium and phosphate: At baseline and as needed
- 25(OH) vitamin D level: To guide supplementation
- PTH level: To determine etiology (PTH-mediated vs. non-PTH-mediated) 2
Chronic Management
- Serum calcium: Weekly initially, then monthly once stable
- 24-hour urine calcium: Monitor for hypercalciuria (risk of nephrolithiasis and nephrocalcinosis) 3
- Renal function: Periodically assess for complications
- Avoid over-treatment: Current therapies are limited by serum calcium fluctuations and complications including hypercalciuria, nephrocalcinosis, and soft tissue calcification 3
Special Considerations
Hypoparathyroidism-Specific Intensification
When standard therapy is insufficient in hypoparathyroidism 3:
- Thiazide diuretics: Reduce urinary calcium excretion
- Phosphate binders: If hyperphosphatemia present
- Low-salt diet: Reduces calcium excretion
- Low-phosphorus diet: Helps manage calcium-phosphate product
Renal Impairment
Denosumab caution: If eGFR <30 mL/min, denosumab can induce prolonged and severe hypocalcemia 4. Bisphosphonates should generally not be used if eGFR <35 mL/min 4.
Pediatric Considerations
For children on chronic glucocorticoids, optimize age-appropriate dietary calcium and vitamin D to meet recommended daily allowances before considering pharmacologic osteoporosis therapy 4.